EYPT

EyePoint, Inc.

SEC CIK 1314102
$13.03 +5.7% · 90 days
90-day buys
$0
0 open-market
90-day sells
$36.6K
1 open-market
Net insider flow
−$36.6K
Net selling
Filings shown
32
Most recent
Advertisement

At a glance

Over the last 90 days, insiders at EYPT have sold a net $36.6K of stock (0 open-market buys vs 1 sell).

Largest recent trade: Cormorant Asset Management, Lp sold $942.2K of EYPT, trimming their stake 1%.

Most active filer: Elston George, with 10 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for EYPT, newest first
View on SEC EDGAR ↗
EYPT
Option exercise Elston George · Chief Financial Officer · Option exercise · filed 2w ago ΔOwn +8.5%
+$0
7,500 sh
EYPT
Tax withholding Elston George · Chief Financial Officer · Tax withholding · filed 2w ago ΔOwn −3.8%
−$46.9K
3,627 sh @ $13
EYPT
Option exercise Ribeiro Ramiro · Chief Medical Officer · Option exercise · filed Apr 20, 2026 ΔOwn NEW
+$20.1K
2,437 sh @ $8
EYPT
Sell Ribeiro Ramiro · Chief Medical Officer · Open-market sale · filed Apr 20, 2026 ΔOwn −100%

Ribeiro Ramiro sold $36.6K of EYPT, trimming their stake 100%.

−$36.6K
2,437 sh @ $15
EYPT
J Duker Jay S. · Director, President and CEO · Other · filed Mar 24, 2026 ΔOwn +76%
+$1.01M
76,766 sh @ $13
Advertisement
EYPT
Buy Duker Jay S. · Director, President and CEO · Open-market purchase · filed Mar 16, 2026 ΔOwn +1.5%

Duker Jay S., EYPT's CEO, spent $19.7K of their own money on 1,500 shares at $13, growing their stake 2%.

+$19.7K
1,500 sh @ $13
EYPT
Option exercise Ribeiro Ramiro · Chief Medical Officer · Option exercise · filed Mar 5, 2026 ΔOwn NEW
+$20.1K
2,438 sh @ $8
EYPT
Sell Ribeiro Ramiro · Chief Medical Officer · Open-market sale · filed Mar 5, 2026 ΔOwn −100%

Ribeiro Ramiro sold $43.6K of EYPT, trimming their stake 100%.

−$43.6K
2,438 sh @ $18
EYPT
Option exercise Ribeiro Ramiro · Chief Medical Officer · Option exercise · filed Feb 18, 2026 ΔOwn NEW
+$20.1K
2,437 sh @ $8
EYPT
Sell Ribeiro Ramiro · Chief Medical Officer · Open-market sale · filed Feb 18, 2026 ΔOwn −100%

Ribeiro Ramiro sold $36.6K of EYPT, trimming their stake 100%.

−$36.6K
2,437 sh @ $15
EYPT
Option exercise Duker Jay S. · Director, President and CEO · Option exercise · filed Jan 7, 2026 ΔOwn +31%
+$0
20,793 sh
EYPT
Tax withholding Duker Jay S. · Director, President and CEO · Tax withholding · filed Jan 7, 2026 ΔOwn −11%
−$169.5K
10,054 sh @ $17
EYPT
Option exercise Elston George · Chief Financial Officer · Option exercise · filed Jan 7, 2026 ΔOwn +19%
+$0
15,285 sh
EYPT
Tax withholding Elston George · Chief Financial Officer · Tax withholding · filed Jan 7, 2026 ΔOwn −4.7%
−$75.7K
4,487 sh @ $17
EYPT
Option exercise Ribeiro Ramiro · Chief Medical Officer · Option exercise · filed Jan 7, 2026 ΔOwn +220%
+$241.6K
29,250 sh @ $8
EYPT
Sell Ribeiro Ramiro · Chief Medical Officer · Open-market sale · filed Jan 7, 2026 ΔOwn −100%

Ribeiro Ramiro sold $727.3K of EYPT, trimming their stake 100%.

−$727.3K
42,544 sh @ $17
EYPT
Option exercise Duker Jay S. · Director, President and CEO · Option exercise · filed Jan 6, 2026 ΔOwn +58%
+$0
30,000 sh
EYPT
Tax withholding Duker Jay S. · Director, President and CEO · Tax withholding · filed Jan 6, 2026 ΔOwn −18%
−$252.8K
14,505 sh @ $17
EYPT
Option exercise Elston George · Chief Financial Officer · Option exercise · filed Jan 6, 2026 ΔOwn +21%
+$0
15,000 sh
EYPT
Tax withholding Elston George · Chief Financial Officer · Tax withholding · filed Jan 6, 2026 ΔOwn −5.2%
−$76.7K
4,403 sh @ $17
EYPT
Option exercise Ribeiro Ramiro · Chief Medical Officer · Option exercise · filed Jan 6, 2026 ΔOwn NEW
+$0
19,667 sh
EYPT
Tax withholding Ribeiro Ramiro · Chief Medical Officer · Tax withholding · filed Jan 6, 2026 ΔOwn −32%
−$111.4K
6,373 sh @ $17
EYPT
Option exercise Duker Jay S. · Director, President and CEO · Option exercise · filed Jan 6, 2026 ΔOwn +652%
+$0
65,000 sh
EYPT
Tax withholding Duker Jay S. · Director, President and CEO · Tax withholding · filed Jan 6, 2026 ΔOwn −31%
−$409.9K
23,447 sh @ $17
EYPT
Option exercise Elston George · Chief Financial Officer · Option exercise · filed Jan 6, 2026 ΔOwn +34%
+$0
19,667 sh
EYPT
Tax withholding Elston George · Chief Financial Officer · Tax withholding · filed Jan 6, 2026 ΔOwn −8.2%
−$110.5K
6,324 sh @ $17
Advertisement

About EYPT insider activity

This page tracks every recent Form 4 filed for EyePoint, Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is EYPT insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for EyePoint, Inc. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.